- Home
- CZFS vs DCTH Comparison
CZFS vs DCTH Comparison
Compare CZFS & DCTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CZFS | DCTH |
|---|---|---|
| Founded | 1984 | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 288.7M | 311.7M |
| IPO Year | 1995 | 2015 |
Fundamental Metrics
Financial Performance| Metric | CZFS | DCTH |
|---|---|---|
| Price | $66.58 | $10.84 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $22.00 |
| AVG Volume (30 Days) | 6.1K | ★ 268.8K |
| Earning Date | 04-30-2026 | 05-07-2026 |
| Dividend Yield | ★ 3.07% | N/A |
| EPS Growth | 30.26 | ★ 107.53 |
| EPS | ★ 7.62 | 0.07 |
| Revenue | ★ $9,881,000.00 | N/A |
| Revenue This Year | N/A | $24.54 |
| Revenue Next Year | $2.64 | $33.15 |
| P/E Ratio | ★ $8.74 | $151.71 |
| Revenue Growth | ★ 2.82 | N/A |
| 52 Week Low | $49.99 | $8.12 |
| 52 Week High | $69.58 | $18.23 |
Technical Indicators
Market Signals| Indicator | CZFS | DCTH |
|---|---|---|
| Relative Strength Index (RSI) | 50.81 | 61.15 |
| Support Level | $53.79 | $10.50 |
| Resistance Level | $68.87 | $11.25 |
| Average True Range (ATR) | 1.92 | 0.37 |
| MACD | -0.15 | 0.05 |
| Stochastic Oscillator | 19.51 | 77.98 |
Price Performance
Historical ComparisonAbout CZFS Citizens Financial Services Inc.
Citizens Financial Services Inc is a Pennsylvania-chartered bank and trust company. The company through its banking subsidiary provides banking activities and services for individual, business, governmental and institutional customers. Its activities and services principally include checking, savings, and time deposit accounts; residential, commercial and agricultural real estate, commercial and industrial, state and political subdivision and consumer loans; and a variety of other specialized financial services. The Trust and Investment division of the Bank offers a full range of client investment, estate, mineral management, and retirement services.
About DCTH Delcath Systems Inc.
Delcath Systems Inc is an oncology company. The company is focused on the treatment of primary and metastatic liver cancers. The firm's product include Melphalan Hydrochloride, Hepzato for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.